- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02676258
Clinical Comparison of Two Daily Disposable Silicone Hydrogel Soft Contact Lens
July 5, 2016 updated by: Visco Vision Inc.
A Prospective Randomized Controlled Study to Evaluate the Clinical Performance of Si-Hy Silicone Hydrogel Soft Contact Lens
The objective of this study is to evaluate a new daily disposable silicone hydrogel soft contact lens by comparing to an existing daily disposable soft contact lens.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study is designed to evaluate the performance of the olifilcon B contact lens to demonstrate substantial equivalence to the narafilcon A for regulatory requirement.
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan
- MayKay Memorial Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Subject should have normal eyes and use no ocular medications
- Subject with -1.00 to -10.00 D myopia, less than 2.00 D astigmatism
- VA correctable to Log MAR 0.1 or better.
- Willing to comply with all study procedures and be available for the duration of the study.
- Provide signed and dated informed consent form.
Exclusion Criteria:
- Subjects have history of allergies that would contraindicate "normal" contact lens wear.
- Subjects have other active ocular or systemic disease such as, but not limited to : anterior uveitis (past or present), glaucoma, Sjögren's syndrome, lupus erythematosus, sclerodermas, keratoconus or type II diabetes.
- Subjects have medications that would contraindicate contact lens wear.
- Currently pregnant (to the best of the subject's knowledge), is lactating or is planning a pregnancy within the next 3 month.
- Current drug or alcohol use or dependence that, in the opinion of the site investigator, would interfere with adherence to study requirements.
- Any active participation in another clinical trial within 30 days prior to this study.
- The presence of clinically significant (grade 3 or 4) anterior segment abnormalities; inflammations such as iritis; or any infection of the eye, lids, or associated structures.
- A known history of corneal hypoesthesia (reduced corneal sensitivity), corneal ulcer, corneal infiltrates or fungal infections.
- A history of papillary conjunctivitis that has interfered with contact lens wear.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Si-Hy soft contact lens
olifilon B daily disposable soft contact lens
|
Wear Si-Hy silicone hydrgel soft contact lens for 3 months
|
|
Active Comparator: Vistakon soft contact lens
narafilcon A daily disposable soft contact lens
|
Wear Vistakon soft contact lens for 3 months
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Acuity
Time Frame: over all follow-up visits for 3 month study period
|
logMAR visual acuity (VA) over all visits.
|
over all follow-up visits for 3 month study period
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Any Slit Lamp Finding > Grade 2
Time Frame: over all follow-up visits for the 3 month study period
|
All dispensed eyes over all follow-up visits.
Measured on a scale of 0-4 with 0=no findings and 4=sever findings.
|
over all follow-up visits for the 3 month study period
|
|
Subjective Response to Comfort, symptoms and complaints
Time Frame: over all follow-up visits for the 3 month study period
|
subjective ratings of comfort, symptom and complaints using a scale of 0=severe stinging/Burning to 10=No stinging/Burning for each eye; 0 represented the least favorable rating and a 100 represented the most favorable rating.
|
over all follow-up visits for the 3 month study period
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Huey Chuan Cheng, MD MS, Mackay Memorial Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2015
Primary Completion (Actual)
November 1, 2015
Study Completion (Actual)
November 1, 2015
Study Registration Dates
First Submitted
January 30, 2016
First Submitted That Met QC Criteria
February 3, 2016
First Posted (Estimate)
February 8, 2016
Study Record Updates
Last Update Posted (Estimate)
July 7, 2016
Last Update Submitted That Met QC Criteria
July 5, 2016
Last Verified
July 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1030313M
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
Tianjin Medical University Eye HospitalNot yet recruitingProgressive Myopia | Pediatric Myopia | Orthokeratology-related Myopia Progression
-
SightGlass Vision, Inc.RecruitingMyopia | Myopia Progression | Juvenile MyopiaUnited States
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitationMyopia, Child Myopia ProgressionChina
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingMyopia | Myopia, ProgressiveChina
-
SightGlass Vision, Inc.Recruiting
-
University of FaisalabadCompletedRefractive Errors | Myopia | Progressive MyopiaPakistan
-
Beijing Airdoc Technology Co., Ltd.Recruiting
-
Beijing Airdoc Technology Co., Ltd.The First People's Hospital of XuzhouRecruiting
-
Shanghai Eye Disease Prevention and Treatment CenterActive, not recruiting
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitation
Clinical Trials on Si-Hy (olifilcon B)
-
Visco Vision Inc.Jens Medical Consulting Ltd.Completed
-
Visco Vision Inc.Completed
-
Vision Service PlanForesight Regulatory Strategies, Inc.CompletedRefractive ErrorsUnited States
-
Dr. Soetomo General HospitalProdia Diacro Laboratories P.T.; Simex Pharmaceutical IndonesiaRecruiting